In Brief: SmithKline Beecham's Nicoderm CQ ad
This article was originally published in The Tan Sheet
Executive Summary
SmithKline Beecham's Nicoderm CQ ad: "Pharmacists and doctors prefer the 3-step method" for smoking cessation employed by the company's OTC nicotine patch, claims an ad running in August and September issues of Prevention, Better Homes & Gardens, Ebony, Life, Parenting and Reader's Digest. "The Nicotrol patch comes in a single strength. That means you can't step down your dose," the ad states. Therefore, the "gradual method" is "preferred by doctors and pharmacists by a wide margin," the ad concludes. The preference claim versus McNeil's Nicotrol is based on an internal study at SmithKline Beecham. The ad was designed by Jordan, McGrath Case & Taylor, New York City...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning